Hakutulokset - Talks, James

Should we still be performing macular laser for non-centre involving diabetic macular oedema? No Tekijä Mueller, Isabella, Talks, James S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Use of optical coherence tomography, fluorescein angiography and indocyanine green angiography in a screening clinic for wet age‐related macular degeneration Tekijä Talks, James, Koshy, Zachariah, Chatzinikolas, Konstantinos

Hae kokoteksti Hae kokoteksti Hae kokoteksti

The use of optical coherence tomography angiography and optical coherence tomography to predict visual acuity in diabetic retinopathy Tekijä DaCosta, Joanna, Bhatia, Devangna, Talks, James

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration Tekijä Cheema, Muhammad Raza, DaCosta, Joanna, Talks, James

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Delayed follow-up of medical retina patients due to COVID-19: impact on disease activity and visual acuity Tekijä Stone, Lydia G., Grinton, Michael E., Talks, James S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Action on sickle cell retinopathy: the time is now Tekijä Dinah, Christiana, Greystoke, Brigit, Mueller, Isabella, Talks, James

Hae kokoteksti Hae kokoteksti Hae kokoteksti

A Comparison of Conventional Intravitreal Injection Method vs InVitria Intravitreal Injection Method Tekijä Blyth, Michelle, Innes, William, Mohsin-Shaikh, Nyma, Talks, James

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Utilisation of optical coherence tomography and optical coherence tomography angiography to assess retinal neovascularisation in diabetic retinopathy Tekijä DaCosta, Joanna, Bhatia, Devangna, Crothers, Oonagh, Talks, James

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Macula service evaluation and assessing priorities for anti-VEGF treatment in the light of COVID-19 Tekijä Stone, Lydia G., Devenport, Adele, Stratton, Irene M., Talks, James S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Extended real-world experience with the ILUVIEN® (fluocinolone acetonide) implant in the United Kingdom: 3-year results from the Medisoft® audit study Tekijä Bailey, Clare, Chakravarthy, Usha, Lotery, Andrew, Menon, Geeta, Talks, James

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes Tekijä Chatziralli, Irini, Regan, Shane O., Mohamed, Ryian, Talks, James, Sivaprasad, Sobha

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization Tekijä Bhatia, Devangna, Mehta, Alexander, DaCosta, Joanna, Crothers, Oonagh, Talks, James Stephen

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Stakeholder Perspectives on Clinical Decision Support Tools to Inform Clinical Artificial Intelligence Implementation: Protocol for a Framework Synthesis for Qualitative Evidence Tekijä Al-Zubaidy, Mohaimen, Hogg, HD Jeffry, Maniatopoulos, Gregory, Talks, James, Teare, Marion Dawn, Keane, Pearse A, R Beyer, Fiona

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence Tekijä Daien, Vincent, Finger, Robert P, Talks, James S, Mitchell, Paul, Wong, Tien Y, Sakamoto, Taiji, Eldem, Bora M, Korobelnik, Jean-François

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes Tekijä Sivaprasad, Sobha, Ghanchi, Faruque, Kelly, Simon P., Kotagiri, Ajay, Talks, James, Scanlon, Peter, McGoey, Hellen, Nolan, Andrew, Saddiq, Moneeb, Napier, Jackie

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update Tekijä Patel, Praveen J, Devonport, Helen, Sivaprasad, Sobha, Ross, Adam H, Walters, Gavin, Gale, Richard P, Lotery, Andrew J, Mahmood, Sajjad, Talks, James S, Napier, Jackie

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Anti-vascular endothelial growth factor in neovascular age-related macular degeneration – a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems... Tekijä Finger, Robert P., Daien, Vincent, Eldem, Bora M., Talks, James S., Korobelnik, Jean-Francois, Mitchell, Paul, Sakamoto, Taiji, Wong, Tien Yin, Pantiri, Krystallia, Carrasco, Joao

Hae kokoteksti Hae kokoteksti Hae kokoteksti

The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice Tekijä Pearce, Ian, Amoaku, Winfried, Bailey, Clare, Downey, Louise, Gale, Richard, Ghanchi, Faruque, Hamilton, Robin, Mahmood, Sajjad, Menon, Geeta, Nosek, Jenny, Talks, James, Yang, Yit

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources Tekijä Daien, Vincent, Eldem, Bora M., Talks, James S., Korobelnik, Jean-Francois, Mitchell, Paul, Finger, Robert P., Sakamoto, Taiji, Wong, Tien Yin, Evuarherhe, Obaro, Carter, Gemma, Carrasco, Joao

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial Tekijä Lois, Noemi, Gardner, Evie, Waugh, Norman, Azuara-Blanco, Augusto, Mistry, Hema, McAuley, Danny, Acharya, Nachiketa, Aslam, Tariq M., Bailey, Clare, Chong, Victor, Downey, Louise, Eleftheriadis, Haralabos, Fatum, Samia, George, Sheena, Ghanchi, Faruque, Groppe, Markus, Hamilton, Robin, Menon, Geeta, Saad, Ahmed, Sivaprasad, Sobha, Shiew, Marianne, Steel, David H., Talks, James Stephen, Adams, Catherine, Campbell, Christina, Mills, Matthew, Clarke, Mike

Hae kokoteksti Hae kokoteksti Hae kokoteksti